Clinical Trial Update: Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis [Phase 1]

View source ↗

Summary

A Phase 1 study assessed the safety and pharmacokinetics of oral and intravenous lefamulin (Xenleta) in adults with cystic fibrosis; results were posted in June…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Xenleta (lefamulin)

Snippet

Sponsor: Nabriva Therapeutics AG | Conditions: Cystic Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2024-06-17